WASHINGTON, D.C. - Eli Lilly & Company, Indianapolis, Indiana, has been approved for membership in the U.S.-Ukraine Business Council (USUBC), the USUBC executive committee announced today on behalf of the entire USUBC membership of over 100 companies and organizations who have business operations, investments or other development programs in Ukraine. has asked to join USUBC.

The company was founded by Eli Lilly in 1876, and is now the 10th largest pharmaceutical company in the world. Their medicines are marketed in 143 countries. Lilly has major research and development facilities in eight countries, conducts clinical trials in more than 50 countries, and has manufacturing plants located in 13 countries.

Lilly is consistently ranked as one of the best companies in the world to work for, and generations of Lilly employees have sustained a culture that values excellence, integrity, and respect for people.

WORKING IN UKRAINE SINCE 1993...FOCUS ON DIABETES CARE
Eli Lilly has been very active on the pharmaceutical market in Ukraine since 1993 with a focus on diabetes care. Lilly has worked hand-in-hand with the Ukrainian government and health care providers to improve patient outcomes. The company is also investing and providing technological expertise in Ukraine.

Lilly enjoys a productive partnership with Ukrainian-based Farmak focused on the local production of insulins. This cooperation is allowing Farmak to produce world class insulin.

JOHN STEELE, DIRECTOR, INTERNATIONAL GOVERNMENT AFFAIRS
Lilly will be represented on the USUBC board of directors by John Steele, Director, International Government Affairs, in the Washington office. John recently transferred from working for Lilly in Vienna, Austria to Washington. He has experience with the pharmaceutical market in Ukraine. John was elected as a new member of the USUBC Executive Committee at the annual meeting in December.

SERGEY KALASHNYK, COUNTRY MANAGER, UKRAINE
Ludmyla Dudnyk, USUBC representative in Ukraine and Morgan Williams, USUBC President/CEO have been working with Sergey Kalashnyk, Lilly's Country Manager for Ukraine, Moldova, and Belarus for the past several months. Sergey has supported USUBC activities, attended meetings and kept USUBC informed about the pharmaceutical market.

Lilly and USUBC have been working together on joint industry actions designed to keep the pharmaceutical sector in Ukraine free of unnecessary governmental intervention and arbitrary price controls. The government of Ukraine has taken some actions in recent months very detrimental in the long-run to the private pharmaceutical industry and Ukrainian consumers.

More information about Eli Lilly & Company can be found at www.lilly.com.

USUBC is very pleased to have Eli Lilly & Company as a member," said Morgan Williams, Director, Government Affairs, Washington Office, SigmaBleyzer Emerging Markets Private Equity Investment Group, www.SigmaBleyzer.com, who serves as President/CEO of the U.S.-Ukraine Business Council (USUBC). "We look forward to working with John Steele as a new member of the USUBC executive committee."

"USUBC now has a membership base of over 100 companies and organizations which allows USUBC to provide its new members such as Eli Lilly & Company with a full-time operation and a significantly expanded program of work," according to USUBC membership director, Iryna Teluk.

USUBC MEMBERSHIP NOW OVER 100 AND STILL GROWING
Over One-Hundred Members, February 2010, Membership in January of 2007 was 22.
The complete list of USUBC members can be found at: http://www.usubc.org/members.php.